Shandong Xinhua Pharmaceutical Company Limited (HKG: 0719)

Shandong Xinhua Pharmaceutical Company Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	996.33	918.33	1,159	744.66	855.77	690.47
Cash & Short-Term Investments	996.33	918.33	1,159	744.66	855.77	690.47
Cash Growth	1.75%	-20.75%	55.61%	-12.98%	23.94%	-12.18%
Accounts Receivable	1,300	949.16	970.63	870.46	518.55	455.23
Other Receivables	17.04	9.65	12.65	17.42	25.16	19.68
Receivables	1,317	958.81	983.28	887.87	543.71	474.91
Inventory	1,192	1,313	1,212	1,028	1,124	1,130
Prepaid Expenses	-	-	-	-	7.15	4.44
Other Current Assets	133.31	124.2	102.95	93.88	155.88	128.23
Total Current Assets	3,639	3,314	3,457	2,754	2,687	2,428
Property, Plant & Equipment	4,151	4,061	4,000	3,766	3,539	3,201
Long-Term Investments	275.61	241.37	239.18	260.2	316.62	296.25
Other Intangible Assets	476.52	494.94	474.11	466.45	449.25	411.59
Long-Term Deferred Tax Assets	16.36	23.48	15.62	15.17	23.52	26.01
Long-Term Deferred Charges	12.58	14.46	8.61	10.54	11.92	-
Other Long-Term Assets	162.75	136.77	69.85	59.99	65.93	72.81
Total Assets	8,734	8,286	8,265	7,332	7,093	6,436
Accounts Payable	1,220	1,178	1,090	1,066	742.9	798.51
Accrued Expenses	45.18	203.11	159.43	122.35	144.87	112.39
Short-Term Debt	378.4	283.96	118.02	269.46	200.42	540
Current Portion of Long-Term Debt	110.57	271.97	714.77	421.03	356.55	289.66
Current Portion of Leases	-	1.78	2.69	2.8	1.56	59.34
Current Income Taxes Payable	23.93	5.03	7.99	12.2	4.42	5.72
Current Unearned Revenue	85.03	149.14	593.26	100.4	377.79	364.95
Other Current Liabilities	750.67	393.16	472.23	507.26	552.53	314.95
Total Current Liabilities	2,614	2,486	3,158	2,502	2,381	2,486
Long-Term Debt	912.19	799.4	545.66	946.2	1,063	589.78
Long-Term Leases	1.16	1.58	2.72	6.77	23.93	51.14
Long-Term Unearned Revenue	91.52	100.67	118.37	133.97	146.5	141.67
Long-Term Deferred Tax Liabilities	115.55	99.21	66.44	65.61	69.31	53.82
Other Long-Term Liabilities	25.06	23.56	23.56	26.46	18.14	3.56
Total Liabilities	3,759	3,510	3,915	3,681	3,702	3,325
Common Stock	682.41	674.68	669.63	627.37	621.86	621.86
Additional Paid-In Capital	1,123	1,055	998.14	677.94	644.91	634.14
Retained Earnings	2,801	2,706	2,345	2,034	1,780	1,530
Comprensive Income & Other	147.72	117.01	113.68	128.37	177.21	183.45
Total Common Equity	4,754	4,553	4,126	3,468	3,224	2,969
Minority Interest	220.58	222.65	223.29	183.2	167.5	141.5
Shareholders' Equity	4,975	4,776	4,350	3,651	3,391	3,111
Total Liabilities & Equity	8,734	8,286	8,265	7,332	7,093	6,436
Total Debt	1,402	1,359	1,384	1,646	1,645	1,530
Net Cash (Debt)	-405.99	-440.36	-225.11	-901.58	-789.42	-839.45
Net Cash Per Share	-0.59	-0.64	-0.34	-1.44	-1.26	-1.35
Filing Date Shares Outstanding	687.88	682.41	669.63	627.37	627.37	621.86
Total Common Shares Outstanding	687.88	674.68	669.63	627.37	621.86	621.86
Working Capital	1,025	828.33	298.47	252.08	305.83	-57.13
Book Value Per Share	6.91	6.75	6.16	5.53	5.18	4.77
Tangible Book Value	4,278	4,058	3,652	3,001	2,775	2,557
Tangible Book Value Per Share	6.22	6.01	5.45	4.78	4.46	4.11
Buildings	-	2,271	2,244	2,078	1,948	1,777
Machinery	-	4,703	4,468	4,011	3,690	3,265
Construction In Progress	-	730.55	545.89	562.96	416.99	392.14

Source: S&P Capital IQ. Standard template. Financial Sources.